A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients

NCT01928147 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: PPI-383
DRUG: Placebo

Sponsor

Presidio Pharmaceuticals, Inc.